Default company panoramic image
Logo

Data Based Medicine Americas Ltd.

DBM will meet the demand for information about the unintended consequences of prescription medications. Currently, this information is not available and the ...

  • Stage Product In Development
  • Industry Healthcare Services
  • Location Toronto, ON, Canada
  • Currency CAD
  • Founded January 2012
  • Employees 0
  • Website RxISK.org

Company Summary

DBM will meet the demand for information about the unintended consequences of prescription medications. Currently, this information is not available and the total annual cost of this gap is estimated to be as high as $100 billion in the US, and $250 billion globally. DBM will collect data directly from patients and health care providers. This information has value to health insurers, pharmaceutical companies, pharmacy chains, and others.

Team

  • Default avatar
    Derelie Mangin
    Chief Medical Officer (CMO)

    A Professor at the University of Otago, NZ, Dee is an internationally respected family physician with expertise in primary care, public health, rational prescribing, epidemiology and clinical research. She is a Minister-appointed expert to the government on comparative assessment and funding priorities for drug treatments and has led studies to detect treatment-induced adverse effects and interventions to reduce these while reducing drug costs.

  • Default avatar
    David Healy
    Chief Executive Officer (CEO)

    CEO and principal founder of DBM, David is an internationally respected psychiatrist, psychopharmacologist, scientist and author. He has been an expert witness in homicide and suicide trials involving psychotropic drugs. He has brought problems with the adverse effets of drugs to the attention of US and UK regulators, raising awareness of how pharmaceutical cos sell drugs by marketing diseases, co-opting academic opinion-leaders and ghostwriting.

  • Default avatar
    Peter Wood
    Chief Operating Officer (COO)

    Chartered Accountant & retired Partner, Ernst & Young LLP (Canada) 1981 to 2009. As President & CEO of EY Electronic Publishing Ltd. Peter was responsible for all aspects of the business, including sales, marketing & communications, forming strategic partnerships, software development, database design, and conceiving, building and maintaining the technology infrastructure. His team of 30 included developers, engineers, marketing & sales staff.

  • Default avatar
    Matt Stinson
    Chief Technology Officer (CTO)

    Matt has taken the lead on the RxISK.org web site development and related infrastructure.
    Matt has spent most of his career as Vice President, Technology for Ernst & Young Electronic Publishing Services Inc. Primarily focusing on creating rich functionality with intuitive design, Matt led the creation of www.knotia.ca, a technology leader within the business research category, maintaining an innovative edge over global publishing competitors.

Advisors

  • Default avatar
    Dimock & Stratton LLP, Lerners LLP
    Lawyer
    Unconfirmed